IMU Biosciences
Funding reported, Series A, last update 3 months ago
Pharma biotech
Everything we hold on IMU Biosciences, newest first. Every line links to the filing or report it came from.
This profile is thin because we hold one source document on IMU Biosciences so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.
- 2026-06-02Headcount Not Stated Growing and expanding
IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M
IMU Biosciences closed an oversubscribed Series A above $53M to decode the immune system for disease diagnosis and treatment, a pharma and biotech scale-up stage where funding typically expands research headcount. The announcement names no hiring plans.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker